Share Price | Marvel Biosciences Corp. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Marvel Biosciences Corp. with Similar Stocks

MYND Life Sciences, Inc.Universal Ibogaine, Inc.Algernon Pharmaceuticals, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 8 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.46

Return on Equity

45.88%

Price to Book

-2.22

Revenue and Profits:

Net Sales:

(Quarterly Results - Oct 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

3.33%

6 Months

-35.42%

1 Year

10.71%

2 Years

19.23%

3 Years

63.16%

4 Years

10.71%

5 Years

-22.5%

Marvel Biosciences Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-191.46%

EBIT to Interest (avg)

-1.69

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.45

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-2.22

EV to EBIT

-5.93

EV to EBITDA

-5.93

EV to Capital Employed

-4.96

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is 0.00% vs 0.00% in Oct 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Oct 2025 is 0.00% vs 40.00% in Oct 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "-0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jul'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jul 2025 is 0.00% vs 0.00% in Jul 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jul 2025 is -29.41% vs 26.09% in Jul 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jul'25",
        "Jul'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-1.30",
          "chgp": "-23.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-0.20",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.20",
          "val2": "-1.70",
          "chgp": "-29.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY

Oct'25

Oct'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.30

-0.20

-50.00%

Interest

0.10

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.30

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Oct 2025 is 0.00% vs 0.00% in Oct 2024

Consolidated Net Profit

YoY Growth in quarter ended Oct 2025 is 0.00% vs 40.00% in Oct 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jul'25

Jul'25

Jul'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.60

-1.30

-23.08%

Interest

0.30

0.10

200.00%

Exceptional Items

-0.60

-0.20

-200.00%

Consolidate Net Profit

-2.20

-1.70

-29.41%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jul 2025 is 0.00% vs 0.00% in Jul 2024

Consolidated Net Profit

YoY Growth in year ended Jul 2025 is -29.41% vs 26.09% in Jul 2024

All Annual Results

Company CV

About Marvel Biosciences Corp.

Marvel Biosciences Corp.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available